Join
Live feed
·
INSIDERFilingvia Quantisnow
Aardvark Therapeutics Inc. logo

Chief Executive Officer Lee Tien-Li bought $160,654 worth of shares (20,000 units at $8.03), increasing direct ownership by 1% to 1,533,384 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AARD· Aardvark Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AARD (Aardvark Therapeutics Inc.) and more on Quantisnow.